Walden and Burgess on President Trump Signing Bipartisan Bill Reauthorizing Animal Drug & Animal Generic Drug User Fee Programs

Press Release

Energy and Commerce Committee Chairman Greg Walden (R-OR) and Health Subcommittee Chairman Michael C. Burgess, M.D. (R-TX) issued the following statement after President Donald Trump signed H.R. 5554, the Animal Drug and Animal Generic Drug User Fee Amendments of 2018, authored by Reps. Markwayne Mullin (R-OK) and Kurt Schrader (D-OR), into law today.

"This reauthorization encourages the development of new, innovative treatments, and ensures that generic animal drugs will be made available. From our country's farmers and ranchers to our pets, it is critical we have the proper medications to care for our animals and protect our nation's food supply," said Chairman Walden and #SubHealth Chairman Burgess. "We are grateful to the leadership of Reps. Mullin and Schrader, who worked tirelessly to ensure this important reauthorization made it to the president's desk before the end of September deadline. We'd also like to thank President Trump for signing this important bill into law. Because of it, our farmers, vets, and families, can keep our animals and pets safe and healthy."

Background:

H.R. 5554 will amend the Federal Food, Drug, and Cosmetic Act to reauthorize user fee programs relating to new animal drugs (Animal Drug User Fee Act or ADUFA) and generic animal drugs (Animal Generic Drug User Fee Act or AGDUFA).

H.R. 5554, passed the Senate on July 31, by unanimous consent. The bill passed the House on July 16, by voice vote. The bill passed the Energy and Commerce Committee in May 2018, by voice vote.

To learn more about H.R. 5554, click here to hear it straight from the dog's mouth.

Source